Cargando…
Anti-Multiple Myeloma Potential of Secondary Metabolites from Hibiscus sabdariffa
Multiple myeloma (MM) belongs to hematological cancers and its incidence is increasing worldwide. Despite recent advances in its therapy, MM still causes many deaths every year. In fact, current therapies sometimes fail and are associated with severe adverse effects, including neurotoxicity. As a pa...
Autores principales: | Malacrida, Alessio, Cavalloro, Valeria, Martino, Emanuela, Cassetti, Arianna, Nicolini, Gabriella, Rigolio, Roberta, Cavaletti, Guido, Mannucci, Barbara, Vasile, Francesca, Giacomo, Marcello Di, Collina, Simona, Miloso, Mariarosaria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651714/ https://www.ncbi.nlm.nih.gov/pubmed/31323932 http://dx.doi.org/10.3390/molecules24132500 |
Ejemplares similares
-
Anti-Multiple Myeloma Potential of Secondary Metabolites from Hibiscus sabdariffa—Part 2
por: Malacrida, Alessio, et al.
Publicado: (2021) -
Evaluation of antitumoral effect of Hibiscus sabdariffa extract on human breast cancer cells
por: Malacrida, Alessio, et al.
Publicado: (2022) -
Another Brick to Confirm the Efficacy of Rigosertib as Anticancer Agent
por: Malacrida, Alessio, et al.
Publicado: (2023) -
From Nature to Synthetic Compounds: Novel 1(N),2,3 Trisubstituted-5-oxopyrrolidines Targeting Multiple Myeloma Cells
por: Listro, Roberta, et al.
Publicado: (2022) -
In Vitro Evaluation of Rigosertib Antitumoral and Radiosensitizing Effects against Human Cholangiocarcinoma Cells
por: Malacrida, Alessio, et al.
Publicado: (2021)